Cross-reactive and pre-existing antibodies to therapeutic antibodies—Effects on treatment and immunogenicity
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Cross-reactive and pre-existing antibodies to therapeutic antibodies—Effects on treatment and immunogenicity
Authors
Keywords
-
Journal
mAbs
Volume 7, Issue 4, Pages 662-671
Publisher
Informa UK Limited
Online
2015-05-12
DOI
10.1080/19420862.2015.1048411
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Assessment and Reporting of the Clinical Immunogenicity of Therapeutic Proteins and Peptides—Harmonized Terminology and Tactical Recommendations
- (2014) G. Shankar et al. AAPS Journal
- The antibody response against human and chimeric anti-TNF therapeutic antibodies primarily targets the TNF binding region
- (2014) K A van Schie et al. ANNALS OF THE RHEUMATIC DISEASES
- Potential induction of anti-PEG antibodies and complement activation toward PEGylated therapeutics
- (2014) Johan J.F. Verhoef et al. DRUG DISCOVERY TODAY
- Tocilizumab for treating rheumatoid arthritis: an evaluation of pharmacokinetics/pharmacodynamics and clinical efficacy
- (2014) Soken-Nakazawa J Song et al. Expert Opinion on Drug Metabolism & Toxicology
- Functional Analysis of the Anti-adalimumab Response Using Patient-derived Monoclonal Antibodies
- (2014) Pauline A. van Schouwenburg et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Dynamics of Inter-heavy Chain Interactions in Human Immunoglobulin G (IgG) Subclasses Studied by Kinetic Fab Arm Exchange
- (2014) Theo Rispens et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Human Anti-IgG1 Hinge Autoantibodies Reconstitute the Effector Functions of Proteolytically Inactivated IgGs
- (2014) R. J. Brezski et al. JOURNAL OF IMMUNOLOGY
- A monoclonal antibody against hinge-cleaved IgG restores effector function to proteolytically-inactivated IgGs in vitro and in vivo
- (2014) Randall J Brezski et al. mAbs
- Complement Is Activated by IgG Hexamers Assembled at the Cell Surface
- (2014) C. A. Diebolder et al. SCIENCE
- IgG Subclasses and Allotypes: From Structure to Effector Functions
- (2014) Gestur Vidarsson et al. Frontiers in Immunology
- Evaluation of Pre-existing Antibody Presence as a Risk Factor for Posttreatment Anti-drug Antibody Induction: Analysis of Human Clinical Study Data for Multiple Biotherapeutics
- (2013) Li Xue et al. AAPS Journal
- Pre-existing IgG antibodies cross-reacting with the Fab region of infliximab predict efficacy and safety of infliximab therapy in inflammatory bowel disease
- (2013) C. Steenholdt et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Autoantibodies to Variable Heavy (VH) Chain Ig Sequences in Humans Impact the Safety and Clinical Pharmacology of a VH Domain Antibody Antagonist of TNF-α Receptor 1
- (2013) M. C. Holland et al. JOURNAL OF CLINICAL IMMUNOLOGY
- Immunogenicity of anti-TNF biologic therapies for rheumatoid arthritis
- (2013) Pauline A. van Schouwenburg et al. Nature Reviews Rheumatology
- The Immunogenicity of Polyethylene Glycol: Facts and Fiction
- (2013) Huub Schellekens et al. PHARMACEUTICAL RESEARCH
- IgE Production to α-Gal Is Accompanied by Elevated Levels of Specific IgG1 Antibodies and Low Amounts of IgE to Blood Group B
- (2013) Theo Rispens et al. PLoS One
- Rheumatoid factor as predictor of response to abatacept, rituximab and tocilizumab in rheumatoid arthritis: Systematic review and meta-analysis
- (2013) R.J. Maneiro et al. SEMINARS IN ARTHRITIS AND RHEUMATISM
- A rheumatoid factor paradox: inhibition of rituximab effector function
- (2013) Jonathan D Jones et al. ARTHRITIS RESEARCH & THERAPY
- Assessing immunogenicity of biosimilar therapeutic monoclonal antibodies: regulatory and bioanalytical considerations
- (2013) Paul Chamberlain Bioanalysis
- Antibodies to IgG4 Hinge Can Be Found in Rheumatoid Arthritis Patients During All Stages of Disease and May Exacerbate Chronic Antibody-Mediated Inflammation
- (2013) Lotte A. van de Stadt et al. Arthritis & Rheumatology
- Antidrug antibodies (ADAb) to tumour necrosis factor (TNF)-specific neutralising agents in chronic inflammatory diseases: a real issue, a clinical perspective
- (2012) Fabien B Vincent et al. ANNALS OF THE RHEUMATIC DISEASES
- Adalimumab elicits a restricted anti-idiotypic antibody response in autoimmune patients resulting in functional neutralisation
- (2012) Pauline A van Schouwenburg et al. ANNALS OF THE RHEUMATIC DISEASES
- Adalimumab: long-term safety in 23 458 patients from global clinical trials in rheumatoid arthritis, juvenile idiopathic arthritis, ankylosing spondylitis, psoriatic arthritis, psoriasis and Crohn's disease
- (2012) Gerd R Burmester et al. ANNALS OF THE RHEUMATIC DISEASES
- Immunogenicity of biological therapeutics
- (2012) Charlotte Krieckaert et al. CURRENT OPINION IN RHEUMATOLOGY
- The immunoglobulin heavy chain locus: genetic variation, missing data and implications for human disease
- (2012) C T Watson et al. GENES AND IMMUNITY
- Epitope characterization of pre-existing and developing antibodies to an aglycosylated monoclonal antibody therapeutic of G1m17,1 allotype
- (2012) Suzanna M. Tatarewicz et al. JOURNAL OF IMMUNOLOGICAL METHODS
- Fc–Fc interactions of human IgG4 require dissociation of heavy chains and are formed predominantly by the intra-chain hinge isomer
- (2012) Theo Rispens et al. MOLECULAR IMMUNOLOGY
- Clinical relevance of serum natalizumab concentration and anti-natalizumab antibodies in multiple sclerosis
- (2012) Anke Vennegoor et al. Multiple Sclerosis Journal
- Rheumatoid factor appearance after tocilizumab treatment seems to predict bad therapeutical response in rheumatoid arthritis
- (2012) César Faillace et al. RHEUMATOLOGY INTERNATIONAL
- Highest clinical effectiveness of rituximab in autoantibody-positive patients with rheumatoid arthritis and in those for whom no more than one previous TNF antagonist has failed: pooled data from 10 European registries
- (2011) K. Chatzidionysiou et al. ANNALS OF THE RHEUMATIC DISEASES
- The human G1m1 allotype associates with CD4+ T-cell responsiveness to a highly conserved IgG1 constant region peptide and confers an asparaginyl endopeptidase cleavage site
- (2011) M M Stickler et al. GENES AND IMMUNITY
- Humoral response to catumaxomab correlates with clinical outcome: Results of the pivotal phase II/III study in patients with malignant ascites
- (2011) Marion G. Ott et al. INTERNATIONAL JOURNAL OF CANCER
- Development of Antidrug Antibodies Against Adalimumab and Association With Disease Activity and Treatment Failure During Long-term Follow-up
- (2011) Geertje M. Bartelds JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- The relevance of tick bites to the production of IgE antibodies to the mammalian oligosaccharide galactose-α-1,3-galactose
- (2011) Scott P. Commins et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Antibodies to constant domains of therapeutic monoclonal antibodies: Anti-hinge antibodies in immunogenicity testing
- (2011) Theo Rispens et al. JOURNAL OF IMMUNOLOGICAL METHODS
- Increased rheumatoid factor interference observed during immunogenicity assessment of an Fc-engineered therapeutic antibody
- (2011) James Araujo et al. JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS
- Anti-galactose-α-1,3-galactose IgE from allergic patients does not bind α-galactosylated glycans on intact therapeutic antibody Fc domains
- (2011) Jeroen J Lammerts van Bueren et al. NATURE BIOTECHNOLOGY
- Increased levels of rheumatoid factors after TNF inhibitor in rheumatoid arthritis
- (2011) José Alexandre Mendonça et al. RHEUMATOLOGY INTERNATIONAL
- The Origins, Specificity, and Potential Biological Relevance of Human Anti-IgG Hinge Autoantibodies
- (2011) Randall J. Brezski et al. TheScientificWorldJOURNAL
- Surprising negative association between IgG1 allotype disparity and anti-adalimumab formation: a cohort study
- (2011) Geertje M Bartelds et al. ARTHRITIS RESEARCH & THERAPY
- Polymorphism and Utilization of Human VH Genesa
- (2010) ERIC C. B. MILNER et al. Annals of the New York Academy of Sciences
- Extent and Clinical Consequences of Antibody Formation Against Adalimumab in Patients With Plaque Psoriasis
- (2010) Lidian L. A. Lecluse et al. ARCHIVES OF DERMATOLOGY
- Subset analysis of patients experiencing clinical events of a potentially immunogenic nature in the pivotal clinical trials of tocilizumab for rheumatoid arthritis: Evaluation of an antidrug antibody ELISA using clinical adverse event-driven immunogenicity testing
- (2010) Kay Stubenrauch et al. CLINICAL THERAPEUTICS
- The immunogenic part of infliximab is the F(ab')2, but measuring antibodies to the intact infliximab molecule is more clinically useful
- (2010) S. Ben-Horin et al. GUT
- Interactions between immunoglobulin G molecules
- (2010) Roald Nezlin IMMUNOLOGY LETTERS
- Rheumatoid factor interference in immunogenicity assays for human monoclonal antibody therapeutics
- (2010) Suzanna Tatarewicz et al. JOURNAL OF IMMUNOLOGICAL METHODS
- A Novel Strategy To Reduce the Immunogenicity of Biological Therapies
- (2010) J. Somerfield et al. JOURNAL OF IMMUNOLOGY
- IgG2m4, an engineered antibody isotype with reduced Fc function
- (2010) Zhiqiang An et al. mAbs
- Human immunoglobulin allotypes
- (2010) Roy Jefferis et al. mAbs
- Cleavage of IgGs by proteases associated with invasive diseases
- (2010) Randall J. Brezski et al. mAbs
- The immunogenicity of humanized and fully human antibodies
- (2010) Fiona A. Harding et al. mAbs
- Immunogenicity of biologic therapies—we need tolerance
- (2010) Charlotte L. M. Krieckaert et al. Nature Reviews Rheumatology
- Thrombocytopenia after abciximab use results from different mechanisms
- (2010) Gisèle Clofent-Sanchez et al. THROMBOSIS AND HAEMOSTASIS
- Evaluation of a biosensor immunoassay for simultaneous characterization of isotype and binding region of human anti-tocilizumab antibodies with control by surrogate standards
- (2009) Kay Stubenrauch et al. ANALYTICAL BIOCHEMISTRY
- Prevalence of human anti-mouse antibodies (HAMAs) in routine examinations
- (2009) Saori Koshida et al. CLINICA CHIMICA ACTA
- Immunogenicity of rituximab in patients with severe pemphigus
- (2009) Enno Schmidt et al. CLINICAL IMMUNOLOGY
- Human IgG4 Binds to IgG4 and Conformationally Altered IgG1 via Fc-Fc Interactions
- (2009) T. Rispens et al. JOURNAL OF IMMUNOLOGY
- IgG1 heavy chain-coding gene polymorphism (G1m allotypes) and development of antibodies-to-infliximab
- (2009) Charlotte Magdelaine-Beuzelin et al. Pharmacogenetics and Genomics
- A Novel Heterophilic Antibody Interaction Involves IgG4
- (2009) T. Ito et al. SCANDINAVIAN JOURNAL OF IMMUNOLOGY
- Formation of antibodies against infliximab and adalimumab strongly correlates with functional drug levels and clinical responses in rheumatoid arthritis
- (2008) T R D J Radstake et al. ANNALS OF THE RHEUMATIC DISEASES
- Immunogenicity of anti-tumor necrosis factor antibodies—toward improved methods of anti-antibody measurement
- (2008) Lucien Aarden et al. CURRENT OPINION IN IMMUNOLOGY
- Recommendations for the validation of immunoassays used for detection of host antibodies against biotechnology products
- (2008) Gopi Shankar et al. JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS
- Cetuximab-Induced Anaphylaxis and IgE Specific for Galactose-α-1,3-Galactose
- (2008) Christine H. Chung et al. NEW ENGLAND JOURNAL OF MEDICINE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now